Squarepoint’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $66.4M | Buy |
|
|||||
|
2025
Q2 | $798K | Sell |
|
|||||
|
2025
Q1 | $1.69M | Sell |
|
|||||
|
2024
Q4 | $30M | Buy |
|
|||||
|
2024
Q3 | $11.7M | Sell |
|
|||||
|
2024
Q2 | $24M | Sell |
|
|||||
|
2024
Q1 | $86.7M | Buy |
|
|||||
|
2023
Q4 | $64.3M | Buy |
|
|||||
|
2023
Q3 | $42.1M | Buy |
|
|||||
|
2023
Q2 | $31.8M | Buy |
|
|||||
|
2023
Q1 | $26.7M | Buy |
|
|||||
|
2022
Q4 | $525K | Sell |
|
|||||
|
2022
Q3 | $7.56M | Sell |
|
|||||
|
2022
Q2 | $18.2M | Buy |
|
|||||
|
2022
Q1 | $6.11M | Buy |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2021
Q2 | – | Hold |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $3.03M | Sell |
|
|||||
|
2020
Q3 | $4M | Buy |
|
|||||
|
2020
Q2 | $464K | Sell |
|
|||||
|
2020
Q1 | $1.28M | Sell |
|
|||||
|
2019
Q4 | $9.02M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.58M | Buy |
|
|||||
|
2019
Q1 | $1.15M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $6.56M | Sell |
|
|||||
|
2018
Q2 | $8.88M | Buy |
|
|||||
|
2018
Q1 | $3.42M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.12M | Buy |
|
|||||
|
2017
Q1 | $554K | Sell |
|
|||||
|
2016
Q4 | $431K | Buy |
|
|||||
|
2016
Q3 | $474K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $502K | Buy |
|
|||||
|
2015
Q4 | $490K | Buy |
|